By Matt Fisher – Remote patient monitoring (the very impersonal nature of that phrase will not be discussed right now) has risen to the forefront in many discussions about how virtual care positively impacts the delivery of healthcare.
Read More
AMA survey shows, health insurer industry continues to show apathetic or ineffectual follow-through on mutually accepted reforms despite mounting evidence that insurer-imposed authorizations for drugs and medical services can be a hazardous and burdensome administrative obstacle to patients.
By Matt Fisher – How should patients be able to access healthcare services? The question is becoming more nuanced given the growth and expansion of telehealth. Prior to COVID-19 driving the implementation of telehealth, access to healthcare services had largely been the same for years. Access focused on patients going to a physician’s office, a hospital, or other facility.
By Devin Partida – The COVID-19 pandemic caused drastic shifts throughout virtually all segments of society. Here are six ways the health crisis influenced trends in the insurance industry.
By Bernard J. Wolfson – In April, San Francisco-based primary care company One Medical revealed an eye-popping compensation package for its chief executive and chairman, Amir Dan Rubin. His $199 million payday, particularly noteworthy at a company that has yet to turn a profit, made Rubin the second-highest-paid CEO in the United States last year — but only on paper.
As new cases of COVID-19 in the United States were peaking in late 2020, most physicians reported that health plans continued to impose bureaucratic prior authorization policies that delay access to necessary care and sometimes result in serious harm to patients, according to new survey results issued by the AMA.
By Kayla Matthews – The Health Insurance Portability and Accountability Act is legislation that defines the privacy and security standards surrounding health information. There’s also a component of HIPAA called the privacy rule.
By Rachel Bluth – Lobbying campaigns and legislative battles have been underway for months as Congress tries to solve the problem of surprise billing, when patients face often exorbitant costs after they unknowingly receive care from an out-of-network doctor or hospital.
By Elisabeth Rosenthal – As voters fume about the high cost of health care, politicians have been targeting two well-deserved villains: pharmaceutical companies, whose prices have risen more than inflation, and insurers, who pay their executives millions in salaries while raising premiums and deductibles.